Navignostics

Horgen, Switzerland

Cancer Precision Medicine Drug Development Companion Diagnostics

Navignostics is a B2B biotechnology company specializing in spatial single-cell proteomics to characterize tumors. Their technology combines highly multiplex tumor imaging with advanced data analytics to identify optimal cancer treatments for individual patients. Additionally, they accelerate cancer drug development by providing critical insights into drug mechanisms and tumor features, facilitating companion diagnostic development. Based in Switzerland, they partner with pharmaceutical companies and researchers to enable personalized medicine strategies and robust technologies that offer biological insights to guide treatment decisions and improve clinical trial success rates through precise biomarker identification.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Navignostics on @MedStartr Today #CancerTherapySelection #SolidTumors #CancerOncology #Cancer #PrecisionMedicine #DrugDevelopment #CompanionDiagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/GxNhP_v8wZ8

Get Involved in Navignostics

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2022
Website: www.navignostics.com/

Disease Areas

Cancer Therapy Selection Solid Tumors Cancer & Oncology

Technologies

Precision Medicine TechCompanion DiagnosticsBiomarker DiscoveryAI-driven Drug Discovery

🌐Website

What do you think of Navignostics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.